Nyxoah SA (EBR:NYXH)
Belgium flag Belgium · Delayed Price · Currency is EUR
6.63
+0.18 (2.79%)
At close: Aug 5, 2025, 5:30 PM CET

Nyxoah Company Description

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA).

The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.

Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Nyxoah SA
Nyxoah logo
CountryBelgium
Founded2009
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees184
CEOOlivier Taelman

Contact Details

Address:
Rue Edouard Belin 12
Mont-Saint-Guibert, 1435
Belgium
Phone32 1 022 23 55
Websitenyxoah.com

Stock Details

Ticker SymbolNYXH
ExchangeEuronext Brussels
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberBE0974358906
SIC Code3841

Key Executives

NamePosition
Olivier TaelmanChief Executive Officer and Executive Director
Robert Taub MBACo-Founder and Chairman
John LandryChief Financial Officer
Bruno OnkelinxChief Technical Officer
Mikaela KirkwoodCorporate Communication and Investor Relations Manager
An MoonenGeneral Counsel
Maggie McGowanChief Human Resources Officer
Loic MoreauPresident of International
Remi RenardChief of Staff
Jeyakumar SubbaroyanChief Clinical Officer